The interplay between cancer and cardiovascular disease

Area of Science:

• Oncology and Cardiology
• Public Health

Background:

• Cancer and cardiovascular disease (CVD) are leading causes of death in Japan.
• Shared risk factors and pathophysiological mechanisms link cancer and CVD, suggesting bidirectional influence.
• Cancer survivors exhibit increased CVD risks, and CVD may predispose individuals to cancer.

Discussion:

• Cancer treatments like chemotherapy can induce cardiotoxicity, elevating CVD risk.
• Hypertension combined with a cancer history, particularly post-chemotherapy, significantly increases CVD event likelihood.
• Existing study limitations necessitate further research into cancer-CVD interrelationships.

Key Insights:

• Cancer survivors with hypertension and chemotherapy exposure are at a heightened risk for cardiovascular events.
• Early and continuous cardiovascular monitoring is essential for cancer survivors.
• The interplay between cancer and CVD demands integrated patient management strategies.

Outlook:

• The evolving field of cardio-oncology requires evidence-based guidelines for managing cancer-related cardiovascular complications.
• Enhanced collaboration between oncologists and cardiologists is crucial for optimizing patient care.
• Future research should focus on refining risk stratification and therapeutic interventions for this high-risk population.